Trial intelligence / Profile preview

VR to Improve Psychological Distress and Anxiety in Primary Brain Tumor Patients

NCT04301089Phase 2Completed

Sponsor
National Cancer Institute
Start
Mar 2021
Primary completion
Feb 2025
Countries
1
01

Overview

Phase 2, open-label, single-arm trial in anxiety disorder and psychological distress, sponsored by National Cancer Institute. Primary endpoints: Number of Participants Who Completed Patient-Reported Outcomes (PROs) Questionnaires, Number of Participants Compliant With Virtual Reality (VR) Headset Use and 2 more. Started Mar 2021; status: completed.

02

Conditions

anxiety disorderpsychological distress

Beyond the preview

Go deeper on NCT04301089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04301089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call